HomeAboutMediaCareersSite MapContactSearch
Geron
PatientsProductsTechnology & ScienceInvestors
print
  • About Geron
    • Executive Management
    • Board of Directors
    • Contact Information
  • Affiliates
    • Geron Bio-Med Ltd
    • TA Therapeutics
  • Licensees
    • ViaGen
    • Merck
    • Roche
    • Sienna
    • Cell Genesys
  • Directions to Geron

Cell Genesys

We initially granted a non-exclusive license to Genetic Therapy, Inc. (GTI), a subsidiary of Novartis AG, to use our telomerase promoter technology to develop an oncolytic virus product. Subsequently, GTI's oncolytic virus business including our license to GTI was acquired by Cell Genesys Inc., which also has its own oncolytic virus program and has continued the research and development of a potential oncolytic virus product.

Visionary Therapeutics
Home | About | Media | Careers | Site Map | Contact | Search
Patients | Products | Technology & Science | Investors
Legal Disclaimer
Copyright © Geron 2008. All rights reserved.
Site design and layout by BFW Interactive